Administration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficits

Life Sciences

Volumn 83, Issue 17-18, 2008, Pages 602-607

  Hoffman, Ann N ^a,b   Cheng, Jeffrey P ^a,b   Zafonte, Ross D ^d,e,f   Kline, Anthony E ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Antipsychotics; Brain injury; Functional recovery; Water maze

Indexed keywords

HALOPERIDOL; ISOFLURANE; RISPERIDONE;

ARTICLE; BRAIN CORTEX LESION; COGNITION; CONTROLLED STUDY; HIPPOCAMPUS; LEARNING; MALE; MOTOR PERFORMANCE; NONHUMAN; RAT; SEDATION; TRAUMATIC BRAIN INJURY;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; BRAIN INJURIES; COGNITION; HALOPERIDOL; MALE; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; RATS; RATS, SPRAGUE-DAWLEY; RISPERIDONE;

RATTUS;

EID: 53249130558     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.08.007     Document Type: Article

References (48)

1. Cheng J.P., Aslam H.A., Hoffman A.N., Zafonte R.D., and Kline A.E. The neurobehavioral benefit conferred by a single systemic administration of 8-OH-DPAT after brain trauma is confined to a narrow therapeutic window. Neuroscience Letters 416 2 (2007) 165-168
2. Didriksen M., Kreilgaard M., and Arnt J. Sertindole, in contrast to clozapine and olanzapine, does not disrupt water maze performance after acute or chronic treatment. European Journal of Pharmacology 542 1-3 (2006) 108-115
3. Dixon C.E., Clifton G.L., Lighthall J.W., Yaghmai A.A., and Hayes R.L. A controlled cortical impact model of traumatic brain injury in the rat. Journal of Neuroscience Methods 39 3 (1991) 253-262
4. Dixon C.E., Kraus M.F., Kline A.E., Ma X., Yan H.Q., Griffith R.G., Wolfson B.M., and Marion D.W. Amantadine improves water maze performance without affecting motor behavior following traumatic brain injury in rats. Restorative Neurology and Neuroscience 14 4 (1999) 285-294
5. Dunn-Meynell A.A., Hassanian M., and Levin B.E. Norepinephrine and traumatic brain injury: a possible role in post-traumatic edema. Brain Research 800 2 (1998) 245-252
6. Elovic E.P., Lansang R., Li Y., and Ricker J.H. The use of atypical antipsychotics in traumatic brain injury. The Journal of Head Trauma Rehabilitation 18 2 (2003) 177-195
7. Elovic E.P., Jasey N.N., and Eisenberg M.E. The use of atypical antipsychotics after traumatic brain injury. The Journal of Head Trauma Rehabilitation 23 2 (2008) 132-135
8. 1) receptor in the anti-amnesic, but not antidepressant-like, effects of the aminotetrahydrofuran derivative ANAVEX1-41. British Journal of Pharmacology 152 2 (2007) 267-279
9. Feeney D.M., and Westerberg V.S. Norepinephrine and brain damage: alpha noradrenergic pharmacology alters functional recovery after cortical trauma. Canadian Journal of Psychology 44 2 (1990) 233-252
10. Feeney D.M., Gonzalez A., and Law W.A. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 217 4562 (1982) 855-857
11. Feeney D.M., Weisend M.P., and Kline A.E. Noradrenergic pharmacotherapy, intracerebral infusion and adrenal transplantation promote functional recovery after cortical damage. Journal of Neural Transplantation & Plasticity 4 3 (1993) 199-213
12. Gemperle A.Y., McAllister K.H., and Olpe H. Differential effects of iloperidone, clozapine, and haloperidol on working memory of rats in the delayed non-matching-to-position paradigm. Psychopharmacology 169 3-4 (2003) 354-364
13. Goldstein L.B., and Bullman S. Differential effects of haloperidol and clozapine on motor recovery after sensorimotor cortex injury in rats. Neurorehabilitation and Neural Repair 16 4 (2002) 321-325
14. Hamm R.J., Dixon C.E., Gbadebo D.M., Singha A.K., Jenkins L.W., Lyeth B.G., and Hayes R.L. Cognitive deficits following traumatic brain injury produced by controlled cortical impact. Journal of Neurotrauma 9 1 (1992) 11-20
15. Hoffman A.N., Malena R.R., Westergom B.P., Luthra P., Cheng J.P., Aslam H.A., Zafonte R.D., and Kline A.E. Environmental enrichment-mediated functional improvement after experimental traumatic brain injury is contingent on task-specific neurobehavioral experience. Neuroscience Letters 431 3 (2008) 226-230
16. Karl T., Duffy L., O'Brien E., Matsumoto I., and Dedova I. Behavioural effects of chronic haloperidol and risperidone treatment in rats. Behavioural Brain Research 171 2 (2006) 286-294
17. Kline A.E., and Dixon C.E. Contemporary in vivo models of brain trauma and a comparison of injury responses. In: Miller L.P., and Hayes R.L. (Eds). Head Trauma: Basic, Preclinical, and Clinical Directions (2001), John Wiley & Sons, NY 65-84
18. Kline A.E., Yan H.Q., Bao J., Marion D.W., and Dixon C.E. Chronic methylphenidate treatment enhances water maze performance following traumatic brain injury in rats. Neuroscience Letters 280 3 (2000) 163-166
19. 1A receptor agonist repinotan HCL attenuates histopathology and spatial learning deficits following traumatic brain injury in rats. Neuroscience 106 3 (2001) 547-555
20. Kline A.E., Massucci J.L., Marion D.W., and Dixon C.E. Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact. Journal of Neurotrauma 19 4 (2002) 415-425
21. 1A receptor agonist 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after experimental traumatic brain injury is not mediated by concomitant hypothermia. Journal of Neurotrauma 21 2 (2004) 175-185
22. Kline A.E., Massucci J.L., Zafonte R.D., Dixon C.E., DeFeo J.R., and Rogers E.H. Differential effects of single versus multiple administrations of haloperidol and risperidone on functional outcome after experimental traumatic brain trauma. Critical Care Medicine 35 3 (2007) 919-924
23. Kobayashi T., Matsuno K., Murai M., and Mita S. Sigma 1 receptor subtype is involved in the facilitation of cortical dopaminergic transmission in the rat brain. Neurochemical Research 22 9 (1997) 1105-1109
24. Kobayashi T., Matsuno K., Nakata K., and Mita S. Enhancement of acetylcholine release by SA4503, a novel sigma 1 receptor agonist, in the rat brain. The Journal of Pharmacology and Experimental Therapeutics 279 1 (1996) 106-113
25. Li M., Fletcher P.J., and Kapur S. Time course of the antipsychotic effect and the underlying behavioral mechanisms. Neuropsychopharmacology 32 2 (2007) 263-272
26. Lombard L.A., and Zafonte R.D. Agitation after traumatic brain injury: considerations and treatment options. American Journal of Physical Medicine & Rehabilitation 84 10 (2005) 797-812
27. Massucci J.L., Kline A.E., Ma X., Zafonte R.D., and Dixon C.E. Time dependent alterations in dopamine tissue levels and metabolism after experimental traumatic brain injury in rats. Neuroscience Letters 372 1-2 (2004) 127-131
28. McDowell S., Whyte J., and D'Esposito M. Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain 121 6 (1998) 1155-1164
29. McIntosh T.K., Yu T., and Gennarelli T.A. Alterations in regional brain catecholamine concentrations after experimental brain injury in the rat. Journal of Neurochemistry 63 4 (1994) 1426-1433
30. Mysiw W.J., and Sandel M.E. The agitated brain injured patient. Part 2: Pathophysiology and treatment. Archives of Physical Medicine and Rehabilitation 78 2 (1997) 213-220
31. 2-receptor occupancy method in the rat. European Journal of Pharmacology 540 1-3 (2006) 87-90
32. Plenger P.M., Dixon C.E., Castillo R.M., Frankowski R.F., Yablon S.A., and Levin H.S. Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Archives of Physical Medicine and Rehabilitation 77 6 (1996) 536-540
33. Rosengarten H., and Quartermain D. The effect of chronic treatment with typical and atypical antipsychotics on working memory and jaw movements in three- and eighteen-month-old rats. Progress in Neuro-psychopharmacology & Biological Psychiatry 26 6 (2002) 1047-1054
34. Sandel M.E., and Mysiw W.J. The agitated brain injured patient. Part 1: definitions, differential diagnosis, and assessment. Archives of Physical Medicine and Rehabilitation 77 6 (1996) 617-623
35. Schotte A., Janssen P.F., Megens A.A., and Leysen J.E. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Research 631 2 (1993) 191-202
36. Schotte A., Janssen P.F., Gommeren W., Luyten W.H., Van Gompel P., Lesage A.S., De Loore K., and Leysen J.E. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology 124 1-2 (1996) 57-73
37. Skarsfeldt T. Differential effect of antipsychotics on place navigation of rats in the Morris water maze. a comparative study between novel and reference antipsychotics. Psychopharmacology 124 1-2 (1996) 126-133
38. Terry Jr. A.V., Hill W.D., Parikh V., Evans D.R., Waller J.L., and Mahadik S.P. Differential effects of chronic haloperidol and olanzapine exposure on brain cholinergic markers and spatial learning in rats. Psychopharmacology 164 4 (2002) 360-368
39. Terry Jr. A.V., Hill W.D., Parikh V., Waller J.L., Evans D.R., and Mahadik S.P. Differential effects of haloperidol, risperidone, and clozapine exposure on cholinergic markers and spatial learning performance in rats. Neuropsychopharmacology 28 2 (2003) 300-309
40. Terry Jr. A.V., Parikh V., Gearhart D.A., Pillai A., Hohnadel E., Warner S., Nasrallah H.A., and Mahadik S.P. Time-dependent effects of haloperidol and ziprasidone on nerve growth factor, cholinergic neurons, and spatial learning in rats. The Journal of Pharmacology and Experimental Therapeutics 318 2 (2006) 709-724
41. Wagner A.K., Sokoloski J.E., Ren D., Chen X., Khan A.S., Zafonte R.D., Michael A.C., and Dixon C.E. Controlled cortical impact injury affects dopaminergic transmission in the rat striatum. Journal of Neurochemistry 95 2 (2005) 457-465
42. Whyte J., Hart T., Schuster K., Fleming M., Polanski M., and Coslett H.B. Effects of methylphenidate on attentional function after traumatic brain injury: a randomized, placebo-controlled trial. American Journal of Physical Medicine & Rehabilitation 76 6 (1997) 440-450
43. Wilson M.S., Gibson C.J., and Hamm R.J. Haloperidol, but not olanzapine, impairs cognitive performance after traumatic brain injury in rats. American Journal of Physical Medicine & Rehabilitation 82 11 (2003) 871-879
44. Yan H.Q., Kline A.E., Ma X., Hooghe-Peters E.L., Marion D.W., and Dixon C.E. Tyrosine hydroxylase, but not dopamine beta-hydroxylase, is increased in rat frontal cortex after traumatic brain injury. NeuroReport 12 11 (2001) 2323-2327
45. Yan H.Q., Kline A.E., Ma X., Li Y., and Dixon C.E. Traumatic brain injury reduces dopamine transporter protein expression in the rat frontal cortex. NeuroReport 13 15 (2002) 1899-1901
46. Yulug B., Yildiz A., Güzel O., Kilic E., Schäbitz W.R., and Kilic E. Risperidone attenuates brain damage after focal cerebral ischemia in vivo. Brain Research Bulletin 69 6 (2006) 656-659
47. Yulug B., Yildiz A., Hüdaoglu O., Kilic E., Cam E., and Schäbitz W.R. Olanzapine attenuates brain damage after focal cerebral ischemia in vivo. Brain Research Bulletin 71 1-3 (2006) 296-300
48. Zhao C., Puurunen K., Schallert T., Sivenius J., and Jolkkonen J. Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury. Behavioural Brain Research 158 2 (2005) 211-220